Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03054584 · ClinicalTrials.gov registry record

Genetic Basis of Melanocytic Nevi

A clinical trial of Melanocytic Nevi, sponsored by University of California, Davis.

Recruiting
Registry status
50
Enrollment target
1
Study location

NCT03054584 is a study of Melanocytic Nevi that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03054584, a study of Melanocytic Nevi, is actively recruiting participants, sponsored by University of California, Davis.

RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

The objective of this protocol is to further elucidate the genetic mutations that drive melanocytic nevi (benign melanocytic neoplasms, moles). This will be performed by whole genome, whole exome, or targeted sequencing of de-identified specimens. Herein, the investigators plan to isolate DNA from de-identified skin biopsy specimens and blood samples: 1. From melanocytic nevi collected by skin biopsy (a shave or punch biopsy). A part of the tissue will be submitted for routine diagnostic dermatopathology and investigational histomorphologic and immunohistochemical analysis. 2. From corresponding normal tissue (blood). DNA isolated from blood will be used as a normal control when analyzing sequencing data to identify somatic mutations in lesional tissue.

Conditions Studied

Interventions

  • OTHER Collecting Nevi

Study Locations (1)

California

  • University of California-Davis, Department of Dermatology - Sacramento

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2017-06-26
Est. Completion 2028-06

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT03054584

The ClinicalTrials.gov registry entry for NCT03054584 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Melanocytic Nevi appearing as the primary indexed condition, and to 1 intervention - of which Collecting Nevi is the first listed.

NCT03054584 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03054584 about?

NCT03054584 is a clinical study titled "Genetic Basis of Melanocytic Nevi". The objective of this protocol is to further elucidate the genetic mutations that drive melanocytic nevi (benign melanocytic neoplasms, moles). This will be performed by whole genome, whole exome, or targeted sequencing of de-identified specimens. Herein, the investigators plan to isolate DNA from ...

What is the current status of trial NCT03054584?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2017-06-26. Estimated completion is 2028-06.

What conditions does trial NCT03054584 study?

This clinical trial studies the following conditions: Melanocytic Nevi.

What interventions are being tested in trial NCT03054584?

The interventions under investigation include: Collecting Nevi (OTHER).

Who is sponsoring clinical trial NCT03054584?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03054584 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.